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Abstract 
Objective: Dental caries is one of the most common diseases in Western countries. Its 
pathoetiology is multifactorial, however, bacteria including Streptococcus mutans and the 
closely related Streptococcus sobrinus are regarded as key factors involved in this process. 
The fact that therapeutic approaches to eradicate these microorganisms are still limited 
prompted us to investigate the treatment potential of photodynamic therapy with the 
photoactive compounds hypericin (HYP) and meso-tetra(hydroxyphenyl)chlorin (mTHPC) 
in-vitro.  
Material and methods: S. mutans and S. sobrinus were cultivated under standard conditions 
and incubated with HYP (Invitrogen, Basel, Switzerland), the liposomal mTHPC derivative 
Foslipos (FOS, Biolitec, Jena, Germany) or a mixture of both at concentrations ranging 
between 0.625 and 10 µg/ml for various time points. Following a thorough washing step, 
bacteria were irradiated with a dental polymerization instrument (400-505 nm). All samples 
were subjected to serial dilutions and spiral plating on blood agar plates. Viable colony counts 
were determined after 48 h in culture. Photosensitizer fluorescence of bacteria was visualized 
by confocal microscopic techniques. 
Results: One hundred percent of S. sobrinus could be killed by a 15 min incubation with 
down to 2.5 μg/ml HYP, 5 μg/ml FOS or a mixture of 1.25 μg/ml of each photosensitizer 
followed by light activation of 120 s. In contrast to S. sobrinus, S. mutans displayed a 
significant dark toxicity for FOS (10–1.25 μg/ml) and no relevant PDT effects using HYP 
(10–0.625 μg/ml) under these conditions. HYP-mediated PDT effects (10 μg/ml) could be 
enhanced to more than 99.9% by prolonging photosensitizer incubation to 30 min and 
fractional illumination (2 x 120 s). Complete eradication of S. mutans was achieved by 
incubation for 15 min with a mixture of 0.625 μg/ml each FOS and HYP and illumination for 
120 s. 
Conclusion: For both S. mutans and S. sobrinus short PDT protocols with FOS and/or HYP 
could be established that completely eradicated these cariogenic bacteria in suspension. Our 
study, however, indicated that careful optimization of PDT conditions may be necessary for 
successful treatment even of closely related bacterial species. In multispecies microbial 
populations the application of photosensitizer combinations for PDT may be useful. 
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Introduction 
The oral cavity harbors a plenitude of microorganisms that together constitute the normal 
flora. However, under pathologic conditions this complex system may be disturbed, 
eventually contributing to the etiology of various inflammatory diseases that may even spread 
outside the cavitas oralis [1].  
The most prevalent of microorganism-related oral diseases is caries. Among the different 
pathogens involved, the contribution of the Gram-positive facultative anaerobic bacteria 
Streptococcus mutans and the related Streptococcus sobrinus are thought to play key roles for 
the progression of this condition [2].  
It is well-known that appropriate oral hygiene strongly reduces the risk for caries, however, 
the current number of affected patients is considerable, creating substantial health care costs 
[3]. In most cases, caries treatment consists of debridement of the oral plaque (i.e. the biofilm 
where the cariogenic species reside within an extracellular polymer matrix) or excavation, 
disinfection and sealing of the infected dentin. The limitations of these non-specific and 
invasive treatment options recently rekindled the interest in a method whose basic effects on 
microorganisms are known since over 100 years: photodynamic therapy (PDT) [4]. Briefly, 
PDT is a non or minimally invasive treatment method relying on the ability of a photoactive 
non-toxic drug (the so-called photosensitizer) to rapidly generate upon activation with light 
free radicals or singlet oxygen that can oxidize cellular constituents and eventually lead to cell 
death [5].  
In the past decades, numerous studies have underlined the potential of PDT to destroy 
bacteria, protozoa, fungi and viruses [6]. Although published data on PDT for oral pathogens 
are comparably limited and most of the studies had been performed in vitro, it had been 
proposed that PDT either alone or in combination with other strategies may be a useful option 
to treat pathogens involved in periodontitis [7], peri-implantitis [8], endodontitis [9] and 
caries [10]. 
Of the broad spectrum of photosensitizers available today, several had been successfully 
applied for PDT on the cariogenic bacteria S. mutans and S. sobrinus. These included tricyclic 
dyes [11–20] or tetrapyrroles belonging to the classes of porphyrines [16,20], chlorins [21], 
and phthalocyanines [22,23]. However, to the best of our knowledge, neither meso-
tetra(hydroxyphenyl)chlorin (mTHPC) nor hypericin (HYP) had been tested for treatment of 
S. mutans or S. sobrinus by PDT. 
mTHPC is currently regarded as one of the most potent second generation photosensitizers. 
While the vast majority of reports concern its high efficiency to destroy cancer cells [24], 
effects on bacteria are anecdotal and only include successful treatment of methicillin-resistant 
Staphylococcus aureus with a liposomal mTHPC formulation [25].  
Hypericin is a phenanthroperylene quinine pigment naturally occuring in plants such as St. 
John’s Wort (Hypericum species). It is currently among the most popular drugs against mild 
depression in complementary medicine. In addition to its potent photo-damaging effects on 
cancer cells [26], several studies indicated that HYP is active against various Gram-positive 
bacteria [27–29].  
With the aim to gain more insight into the potential and effects of new photosensitizers for 
clinical applications, in the present study, we investigated for the first time the antimicrobial 
effects of mTHPC and HYP alone or in combination in PDT on the cariogenic Gram-positive 
bacteria S. mutans and S. sobrinus.  
 
Materials and Methods 
Bacterial culture 
S. mutans (OMZ 918) and S. sobrinus (OMZ 176) were obtained from the culture collection 
of the Institute of Oral Biology, University of Zurich, Switzerland and routinely grown 
aerobically over night at 37°C in fluid universal medium (FUM) as described by Gmür and 
Guggenheim [30] until late log phase.  
 
Photosensitizers 
Foslipos (FOS), a novel liposomal uncharged mTHPC compound was kindly donated by 
Biolitec, Jena, Germany. A stock solution (1.5 mg/ml) of FOS was prepared in water. HYP 
was purchased from Invitrogen, Basel, Switzerland and dissolved as a stock at 1 mg/ml in 
ethanol. All photosensitizer stock solutions were kept at 4°C in the dark and further diluted in 
FUM. 
 
Confocal microscopy 
After incubations of bacteria in the dark with FOS or HYP (5 μg/ml) for 5, 15 or 30 min 
respectively, all samples had been fixed by drying on microscopic slides and mounted in 
gycergel (Dako, Glostrup, Denmark). Analyses were performed with a confocal laser 
scanning microscope (TCS SP2 and SP5, Leica, Wetzlar, Germany).  
 
PDT protocols 
Planktonic bacteria were centrifuged and FUM was replaced by FOS (0.625–10 μg/ml), HYP 
(0.625–10 μg/ml) or a 1:1 mixture of both (0.625–10 μg/ml each). Bacteria were incubated for 
1–30 min at 37°C in the dark, followed by two thorough washing steps in physiological NaCl 
solution. Thereafter samples were exposed at a 3 cm distance to culture surface to visible light 
from a halogen polymerization device (Optilux500, KerrHawe, Bioggio, Switzerland) for 120 
s. According to the specifications of the manufacturer, this lamp has a wavelength range of 
400-505 nm and an intensity of 1070 mW/cm2. The light source had an illuminance of 40,000 
lx at the surface and of 21,400 lx at the bottom of the incubation tube. Additional experiments 
were performed as a sequential light application for two times 120 s, with a 30 min vortex 
step in between.  
Numbers of viable colony forming units (CFU) were obtained after 48 h from serial dilutions 
of all samples in FUM and spiral plating on Columbia blood agar base (Becton, Dickinson 
and Co., Le Pont de Claix, France) supplemented with 5% hemolyzed human blood. Controls 
included the following: bacteria received (1) no treatment (neither light nor photosensitizer), 
(2) only photosensitizers, but no light (“dark toxicity”) and (3) no photosensitizer, but light.  
 
Data analyses and statistics 
All experiments were at least performed in triplicate. Data are presented as means with 
standard deviations of the mean. Data were normalized against untreated controls (set to 
100%) and expressed as a percentage surviving or killed bacteria of these untreated controls. 
The t-tests were regarded as significant with p-values ≤ 0.05. 
 
Results 
Streptococcus sobrinus  
Microscopic analyses showed that incubations with FOS and HYP lead to a pronounced 
fluorescent signal at S. sobrinus already after 5 min. The fluorescence intensity was further 
increased after 15 min but did not appear to be considerably stronger after 30 min incubation 
(Fig. 1). 
Controls indicated that growth of untreated S. sobrinus was not impaired by irradiation with 
the dental polymerization tool. Furthermore, when compared to untreated controls, no 
significant dark toxic effects were detected after incubations with FOS or HYP (0.625–
10 μg/ml) without light activation. In untreated controls an average of 2.16E+8 CFU/ml was 
obtained.  
When irradiated after incubation with photosensitizers, a strong PDT effect was elicited, 
resulting in 100% bacterial death at concentrations between 10 and 2.5 µg/ml HYP or 10 and 
5 µg/ml FOS, when incubated for 15 min and light activated for 120 s. A reduced bacterial 
count of ≤ E+05 was still observed down to 1.25 μg/ml FOS or HYP, respectively (Fig. 2). 
Generally, PDT with FOS resulted in higher CFU counts (in the order of 10-fold) compared to 
PDT with HYP. This observation was most apparent at low photosensitizer concentrations 
and is exemplified in Fig. 2. 
Application of MIX for 15 min and illumination for 120 s revealed that S. sobrinus could be 
100% eradicated using concentrations between 5 and 1.25 μg/ml of each of the 
photosensitizers, while the lower concentrated mixture (each photosensitizer 0.625 μg/ml) led 
only to a 1.53E+02 fold reduction of CFU counts (Fig. 3). In comparative analyses of 
treatment effects with single photosensitizers we found that the bactericidal activity of the 
MIX with 1.25 μg/ml of each FOS and HYP was the same as with 2.5 μg/ml HYP alone (Fig. 
2). Neither PDT with FOS nor HYP at 1.25 μg/ml led to a complete destruction of S. sobrinus 
(99.988% and 99.998%, respectively). 
 
Streptococcus mutans 
In S. mutans, we observed a fluorescence pattern in confocal microscopy that was comparable 
to that in S. sobrinus with a maximum signal being reached after 15 min incubation with 
either photosensitizer (Fig. 4). Controls consisting of illumination only indicated no light 
sensitivity of S. mutans. In this bacterial strain, untreated controls reached a mean 4.16E+07 
CFU/ml.  
Studies dealing with possible dark toxic effects revealed that treatment with FOS between 
0.625 and 10 μg/ml was already effective in killing 97.500–99.999% of bacteria without light 
activation (Fig. 5). Additional treatment with light further improved destruction of bacteria at 
all FOS concentrations investigated, ranging from 100% at concentrations between 10 and 
1.25 μg/ml to 99.997% at the lowest concentration tested (0.625 μg/ml) (Fig. 5).  
In contrast to FOS, not even the highest concentrations of HYP displayed a toxicity in the 
dark (mean bacterial survival rate of 88.923% at 10 µg/ml HYP compared to controls). 
However, when bacteria were irradiated (120 s) after incubations with HYP bacterial survival 
rates still came to high values. Even PDT with 10 μg/ml HYP only resulted in a E+02 
reduction in S. mutans, while with low concentrations (1.25 μg/ml or 0.625 μg/ml) 65.965% 
or 90.894%, respectively, of bacteria survived (Fig. 6). Using the highest concentration of 
HYP (10 μg/ml) in combination with a prolongation of photosensitizer incubation time to 
30 min and sequential light application of 2 x 120 s, a 99.988 % destruction of bacteria could 
be achieved (Fig 6).  
Generally, the 1:1 mixture of photosensitizers displayed the same dark toxicity as the 
respective concentrations of FOS alone. To obtain informations about PDT using the MIX we 
focused only on 0.625 μg/ml of each photosensitizer, since this concentration showed a 
significant PDT effect for FOS when compared to its dark toxicity (p=0.0063). While we 
found that under the above conditions PDT with the MIX completely (100%) eradicated S. 
mutans, PDT with neither FOS nor HYP alone at concentrations of 0.625 μg/ml was able to 
do so (survival rate: 0.002% and 90.89%, respectively; Fig. 7). The same 100% effect could 
be obtained by PDT with 1.25 μg/ml FOS (Fig. 7).  
 
Discussion 
PDT is characterized by features that make this treatment modality especially attractive to 
combat microbial pathogens. These include its efficacy on antibiotic-resistant strains, its 
broad target spectrum as well as its very low potential for mutagenicity and photoresistance 
[6]. However, of the large spectrum of photoactive agents available to date only a limited 
number had been explored so far as regards to their antimicrobial applicability.  
To the best of our knowledge, our study is the first to investigate bactericidal PDT effects of 
mTHPC (FOS) or HYP on S. sobrinus and S. mutans. However, PDT data from previous 
studies in mutans streptococci are available for a few other photosensitizers, including 
toluidine blue O [11,12,14,17,18,20], methylene blue [16,19], erythrosine [15,16], 
hematoporphyrin derivative [16,20], native and lysine-conjugated chlorin e6 [21], aluminium 
disulphonated or cationic Zn(II) phthalocyanine [22,23], and Rose Bengal [13]. Our results as 
well as the vast majority of the above published data underlined the usefulness of PDT to 
destroy mutans streptococci, supporting the general observation that Gram-positive bacteria 
are susceptible to inactivation by photodynamic procedures [31]. Since many experimental 
parameters such as cell culture conditions, photosensitizer concentrations and their incubation 
times, light sources, illumination intensities and times considerably differ between studies and 
our setup, a comparison of experiments is only of limited value.  
However, when analyzing data or establishing protocols, it should be kept in mind that with 
respect to the extremely fast growth of mutans streptococci, PDT killing rates of bacteria may 
be statistically significant but clinically insufficient. Our study shows that short PDT 
protocols with FOS and HYP can be established that have the capacity to completely kill 
these bacteria in suspension. Among all previously published studies, only two also used 
planktonic cultures (S. mutans) as models, showing that PDT protocols with either 0.5 μg/ml 
Rose Bengal or 100 μg/ml toluidine blue O resulted in a complete bacterial eradication 
[13,18]. All PDT reports dealing with single- or multispecies oral biofilms (with mutans 
streptococci) were only able to reduce viable bacterial counts [14–17,19,20,23]. It is well-
known that pathogens organized in biofilms are more resistant towards antimicrobial 
modalities as compared to planktonic cultures. This may also hold true for our PDT protocols, 
since preliminary studies with mutans streptococci grown in sucrose-supplemented media 
also displayed a reduced bactericidal efficiency [Besic Gyenge et al., in preparation].  
As light source, in our study, we used a halogen hand-held unit routinely applied for 
polymerization of light-cured dental materials. Successful elimination of bacteria in our 
setting indicated that it may be an interesting alternative to the commonly used lasers; 
especially since the polymerization tool is safer, cheaper and readily available in most 
dentist’s offices. While for cancer PDT light sources with longer wavelengths are preferred 
because of deeper penetration needs, the superficial sites of cariogenic bacteria are easily 
accessible with our device. Its wavelength range (400-505 nm) is perfectly suitable for 
activation of FOS, since the Soret band of this photosensitizer is at 420 nm [32]. The 
spectrum of HYP contains a very broad absorption band near 460 nm but, notably, main 
peaks are outside the wavelength range of our lamp [33]. Our study is not the first using non-
laser light for PDT [34] and previously, another brand of hand-held photopolymerizer had 
been successfully applied for activation of Rose Bengal in S. mutans [13].  
Both S. mutans and S. sobrinus are traditionally grouped in a common taxonomic cluster – the 
mutans group – based on shared phenotypic reactions. The strongly different experimental 
sensitivity of the two streptococcus species observed in our study was therefore rather 
unexpected and question the close relationship. Our data support earlier molecular 
phylogenetic analyses of glucan-producing enzymes and superoxide dismutases indicating 
that the two bacteria are in fact genetically separate [35–37]. From in-vitro cancer studies – 
including our own (unpublished data) – the different behavior of photosensitizers in related 
types of tumor cells is actually well-known, underlining the complexity of biomechanisms 
initiated by PDT. 
Basically, the observed differences in sensitivity concerned two parameters: (1) high levels of 
dark toxicity of FOS in S. mutans vs. S. sobrinus and (2) ineffectiveness of HYP-mediated 
PDT in S. mutans – at least under the conditions effective in S. sobrinus.  
Currently, no comparable data of our mTHPC formulation are available for other 
microorganisms. In ongoing studies we are thus investigating as to whether S. mutans has an 
extremely high tolerance or S. sobrinus is extraordinarily sensitive towards this compound. 
However, we propose that the observed dark toxic effects of FOS should not impose any 
clinical treatment consequences. In contrast, inefficiency of HYP-mediated PDT in S. mutans 
under the same experimental conditions as in S. sobrinus would necessitate the development 
of protocol modifications. Since our microscopic analyses indicated that the fluoresence 
signal of HYP was morphologically not different from that of S. sobrinus we conclude that 
lack of adherence and/or uptake was not the underlying problem. Details of these processes, 
however, have not been investigated here. Notably, the light source used in our setting had a 
sub-optimal wavelength range for activation of HYP. The improvement of PDT effects by a 
fractionated illumination may indicate that the failure with our standard protocols is – at least 
in part – related to this factor. Our data are in line with earlier studies showing that HYP-
mediated PDT effects can be enhanced by sequential light application [38]. Another critical 
factor may be the known complexity of HYP biological effects [39]. These appear to involve 
an array of light-dependent and -independent mechanisms whose roles may vary under 
different circumstances. It had been e.g. reported that HYP activity may be strongly and 
specifically protein-dependent, resulting in either promotion or inhibition of PDT effects in 
the presence of certain highly related isoforms of glutathione S-transferases [40]. The HYP 
used in our study was a plant extract of 99% purity (according to the manufacturer’s 
specification) and the remaining 1% unspecified herbal components may have further 
contributed to the observed differences of bioeffects. In none of our experiments, however, 
we observed increased growth rates after treatment with HYP as reported for S. aureus [41].  
In our study we also investigated the consequences of a combined application of FOS and 
HYP for PDT. While this is the first report on mutans streptococci, combinatorial 
photosensitizer approaches have been investigated before in a limited number of studies. In S. 
aureus, the combination of HYP and mTHPC was reported to be counterproductive since 
bacterial growth was stimulated and PDT effects inhibited [41], while in contrast the 
combination of mTHPC and hematoporphyrin derivative resulted in a superior (additive) PDT 
effect in this species [42]. In human endometrial cancer cells, in a breast cancer patient as 
well in a mouse mammary cancer model photosensitizer combinations (5-aminolaevulinic 
acid/HYP and Photofrin II/meso-tetra-(4-sulfonatophenyl)-porphine, respectively) led to an 
enhanced phototoxicity [43,44]. To explore possible advantages of a FOS/HYP combination 
in our model system, we focused on concentrations for photosensitizers that – when given 
alone – were unable to completely kill S. mutans or S. sobrinus. With both bacteria 
investigated here, PDT after a short incubation with the MIX completely sterilized planktonic 
cultures, indicating the high efficiency of this treatment procedure. Of note, PDT with 
1.25 µg/ml FOS in S. mutans or with 2.5 µg/ml HYP in S. sobrinus had the same effect 100% 
killing effect as the respective optimal MIX. Therefore, the effects of low-dose single 
photosensitizers was enhanced in the MIX, but no clear advantage towards the application of 
the total dose by a single photoactive compounds was evident in our setup. However, in many 
clinical settings, multispecies microbial communities have to be treated. Given a non-uniform 
response of these pathogens towards certain photosensitizing agents (as in our models of 
cariogenic bacteria), the application of mixtures may have distinct advantages by targeting a 
whole array of microorganisms in one treatment session.  
 
Conclusions 
Our study provides further support that PDT with second generation photosensitizers may be 
an effective treatment modality to eradicate cariogenic pathogens. Short protocols within less 
than 20 min treatment time may be feasible. The differential results on closely related 
bacterial species, however, indicates how little we actually understand the factors that govern 
PDT-generated cell death in bacteria. For the achievement of clinically relevant effects, great 
care must be taken to adjust PDT parameters depending on specific microoorganisms to be 
targeted. Future investigations of molecular and cellular events elicited by photosensitizer 
incubation and PDT may reveal whether reduced doses of photosensitizers applied in a 
combinatorial treatment will result in favorable clinical effects, e.g. with regards to immune 
responses in vivo. However, the strength of mixtures of photosensitizers for antimicrobial 
PDT may reside in their potential to target complex microbial populations such as in 
supragingival plaque. 
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Zusammenfassung 
Hypericin- und mTHPC-vermittelte photodynamische Therapie zur Behandlung 
kariogener Bakterien 
 
Zielsetzung: Karies gehört zu den häufigsten Erkrankungen in den westlichen Ländern. 
Wenngleich vermutlich multiple Faktoren eine ursächliche Rolle spielen, so wird doch den 
verwandten Bakterien Streptococcus mutans und Streptococcus sobrinus eine Schlüsselrolle 
für die Pathoetiologie von Karies zugesprochen. Da geeignete antibakterielle Behandlungs-
möglichkeiten zur Zeit fehlen, haben wir in der vorliegenden Arbeit das Potential von 
photodynamischer Therapie (PDT) mit den photoaktiven Substanzen Hypericin (HYP) und 
meso-Tetra(hydroxyphenyl)chlorin (mTHPC) in vitro untersucht. 
Material und Methoden: S. mutans und S. sobrinus wurden routinemässig kultiviert und mit 
HYP (Invitrogen, Basel, Schweiz), dem liposomalen mTHPC-Derivativ Foslipos (FOS, 
Biolitec, Jena, Deutschland) oder einer Mischung aus beiden mit Konzentrationen von 0,625–
10 µg/ml unterschiedlich lang inkubiert. Nach sorgfältigen Wasch-Schritten wurden die 
Bakterien mit einer zahnärztlichen Polymerisationslampe bei 400-505 nm bestrahlt. Die 
Proben wurden dann seriell verdünnt und auf Blut-Agar-Platten ausspiralisiert. Überlebende 
Kolonien wurden nach 48 h ausgezählt. Ausserdem wurde die Fluoreszenz der Photo-
sensibilisatoren an den Bakterien mit einem Konfokalmikroskop untersucht.  
Ergebnisse: S. sobrinus konnte zu 100% abgetötet werden durch eine 15-minütige Inkubation 
mit 2,5 μg/ml HYP, 5 μg/ml FOS oder einer Mischung von 1,25 μg/ml beider Photo-
sensibilisatoren und anschliessender Lichtaktivierung für 120 s. Im Gegensatz zu S. sobrinus 
zeigte S. mutans unter diesen Bedingungen eine signifikante Dunkeltoxizität für FOS (10–
1,25 μg/ml) und keine relevanten PDT-Effekte für HYP (10–0,625 μg/ml). HYP-bedingte 
PDT-Effekte (10 μg/ml) konnten aber durch Verlängerung der Inkubationszeit auf 30 min und 
eine fraktionierte Bestrahlung (2x120 s) auf mehr als 99.9% erhöht werden. Eine vollständige 
Eliminierung von S. mutans konnte durch eine 15-minütige Behandlung mit einer Mischung 
von je 0,625 μg/ml FOS und HYP und einer Belichtung von 120 s erzielt werden.  
Schlussfolgerungen: Sowohl für S. mutans wie auch für S. sobrinus konnten kurze PDT-
Protokolle mit FOS und/oder HYP entwickelt werden, welche zur vollständigen Abtötung 
dieser beiden kariogenen Keime in Suspension führten. Unsere Studie zeigte aber auch, dass 
die Behandlung verwandter Keime eine sorgfältige Optimierung der PDT-Bedingungen 
notwendig machen kann. Die Verwendung von Photosensibilisator-Kombinationen könnte für 
die Therapie von mikrobiellen Multispezies-Populationen hilfreich sein.  
 
Schlüsselwörter: Photodynamische Therapie; Bakterien; mTHPC; Hypericin; Gram-positiv 
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Figure legends 
 
Fig. 1. Streptococcus sobrinus after incubation with Foslipos (a-c) and hypericin (d-f) in the 
dark. Confocal microscopy was performed after incubation times of 5 min (a, d), 15 min (b, e) 
and 30 min (c, f). Images were acquired with a x63, 1.4 numerical aperture oil immersion 
objective lens providing an optical section thickness of 200 nm. 
 
Fig. 2. Photodynamic effects in Streptococcus sobrinus. Photosensitizers (Foslipos and/or 
hypericin) at the concentrations indicated had been incubated for 15 min and light (400-
505 nm) was applied for 120 s. 
 
Fig. 3. Photodynamic effects in Streptococcus sobrinus after 15 min incubation with varying 
concentrations of a 1:1 mixture of the photosensitizers Foslipos and hypericin and 
illumination (400-505 nm) for 120 s.  
 
Fig. 4. Streptococcus mutans after incubation with Foslipos (a-c) and hypericin (d-f) in the 
dark. Confocal microscopy was performed after incubation times of 5 min (a, d), 15 min (b, e) 
and 30 min (c, f). Images were acquired with a x63, 1.4 numerical aperture oil immersion 
objective lens providing an optical section thickness of 200 nm. 
 
Fig. 5. Incubation of Streptococcus mutans with varying concentrations of Foslipos for 
15 min with consecutive light activation (120 s) or without light activation.  
 
Fig. 6. Effects of hypericin incubated for either 15 min or 30 min in Streptococcus mutans. 
Bacterial cultures had been either kept in the dark (no light), or illuminated for 15 min (1 x 
light) and two times 15 min with an intermittant vortex step of 30 s (2 x light).  
 
Fig. 7. Photodynamic effects in Streptococcus mutans. Photosensitizers (Foslipos and/or 
hypericin) at the concentrations indicated had been incubated for 15 min and light (400-
505 nm) was applied for 120 s. 
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